AmPath Central Reference Laboratory:
Door No. 1-100/1/CCH Nallagandla, Serilingampally
Hyderabad – 500019
040 6719 9977
www.ampath.com
PATIENT INFORMATION REFERRED BY SPECIMEN INFORMATION
Mrs. CH RAJITHA ..... SAMPLE TYPE :Nasopharyngeal &
RIYA DIAGNOSTIC CENTRE Oropharyngeal Swabs
AGE : 30Y ORDER REQ. NO :OREQ-LAB-21-2460830
GENDER : Female Lab MR #: 4844845 LAB ORDER. NO :2114187909
PRIORITY : Routine COLLECTED ON :22-May-2021 00:00
OP / IP / DG # : RECEIVED ON :22-May-2021 23:49
REPORT STATUS :Completed
RIYA DIAGNOSTIC CENTRE - MR#:
S113381863626
MOLECULAR DIAGNOSTICS
Test Name (Methodology) Result UOM
SARS-CoV-2 (COVID 19) Qualitative
(Real Time PCR) NEGATIVE
Test Observations:
Result Interpretation:
Result Remarks
Positive RNA specific to SARS-CoV-2 Detected
Negative RNA specific to SARS-CoV-2 Not Detected
Indeterminate This could be due to low viral load in the sample.
Repeat sample is recommended for confirmation
Note:
1. This report is pertaining to the sample provided.
2. Sensitivity of this test depends on the sample type submitted and stage of the infection.
3. Negative results do not rule out the possibility of COVID-19 virus infection. A number of factors could lead to a negative result, not limited to
Technical reasons inherent to the test, e.g. virus mutation or PCR inhibition
Viral load lower than limit of detection of the testing kit
Quality of the specimen.
4. Test conducted as per guidelines recommended by WHO and on the kits approved by ICMR/ CE-IVD/ USFDA.
5. The test result should be used in conjunction with clinical presentation.
6. Kindly consult referring Physician / Authorized Govt. hospital for appropriate follow-up.
7. Lower respiratory tract samples like BAL, ET aspirate are appropriate samples especially in severe and progressive lung disease.
Comments:
ICMR registration number for COVID-19 testing - AIPLH001.
COVID-19 is a new strain discovered in 2019 and belongs to large family of Coronaviruses and known to cause diseases such as Middle
East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).
Reported illness have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases. Symptoms like fever, cough
and shortness of breath may appear 2-14 days after exposure.
The SARS-CoV-2 detection is a real-time PCR technology based test, for the qualitative detection and differentiation of lineage B-β Corona
virus (B-βCoV) and severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) specific RNA.
All test results are communicated to ICMR and to the respective local/state authorities as per the existing rules and regulations.
Dr. Haroon Hussain Syed
Checked by Mr. Chandrashekar V Consultant - Microbiology
Technologist 23-May-2021 07:20
-----End of Report-----
Generated On 23-May-2021 07:21:10 705.0048 This is an electronically authenticated laboratory report. Page 1 of 2
AmPath upholds rigorous standards for operational and clinical performance based on US hospital benchmarks. Test results have been furnished in adherence with
these standards and under the terms and conditions found on the reverse. For details, please email AmPath at [email protected].
AmPath Central Reference Laboratory:
Door No. 1-100/1/CCH Nallagandla, Serilingampally
Hyderabad – 500019
040 6719 9977
www.ampath.com
PATIENT INFORMATION REFERRED BY SPECIMEN INFORMATION
Mrs. CH RAJITHA ..... SAMPLE TYPE :Nasopharyngeal &
RIYA DIAGNOSTIC CENTRE Oropharyngeal Swabs
AGE : 30Y ORDER REQ. NO :OREQ-LAB-21-2460830
GENDER : Female Lab MR #: 4844845 LAB ORDER. NO :2114187909
PRIORITY : Routine COLLECTED ON :22-May-2021 00:00
OP / IP / DG # : RECEIVED ON :22-May-2021 23:49
REPORT STATUS :Completed
RIYA DIAGNOSTIC CENTRE - MR#:
S113381863626
MOLECULAR DIAGNOSTICS
Test Name (Methodology) Result UOM
Tests marked with (*) are not included in the scope of NABL accreditation
Generated On 23-May-2021 07:21:10 705.0048 This is an electronically authenticated laboratory report. Page 2 of 2
AmPath upholds rigorous standards for operational and clinical performance based on US hospital benchmarks. Test results have been furnished in adherence with
these standards and under the terms and conditions found on the reverse. For details, please email AmPath at [email protected].
